Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide represents a GLP-1 receptor agonist that works by slowing gastric emptying and increasing satiety signals to the brain. The medication comes in standardized dose escalations, but understanding the full dosing spectrum helps patients and providers make informed treatment decisions. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies, with dosing flexibility built into personalized treatment plans.
Standard Semaglutide Dose Range for Weight Loss
Semaglutide dosing begins at 0.25 mg weekly and increases incrementally over 16 weeks to reach a maintenance dose. The initial four-week period introduces 0.25 mg once weekly, followed by increases to 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg at four-week intervals. This gradual escalation—called titration—allows the body to adapt to the medication while minimizing side effects like nausea or gastrointestinal discomfort.
The maximum approved semaglutide dose for chronic weight management is 2.4 mg injected subcutaneously once per week. Clinical trials demonstrated that patients receiving 2.4 mg achieved average weight reductions of 15% of body weight over 68 weeks compared to placebo. However, not all patients require the maximum dose; some achieve meaningful results at 1.7 mg or lower maintenance doses based on individual response and tolerance.
How Semaglutide Dose Titration Works in Practice
Dose titration is the step-wise increase of medication over weeks to months, designed to improve tolerability while reaching therapeutic benefit. During the first week, patients inject 0.25 mg and may experience mild appetite suppression; by week five, the dose increases to 0.5 mg. This measured approach reduces the likelihood of severe nausea, vomiting, or constipation that can occur when dosing escalates too rapidly.
Most patients tolerate dose increases well, though some experience temporary gastrointestinal adjustments at each step. If side effects become problematic, prescribers may hold the current dose for an extra week or two before advancing, allowing the body time to acclimate. PlexusDx works with healthcare providers to customize titration timelines based on individual tolerance patterns and treatment goals, ensuring each patient reaches their optimal therapeutic dose comfortably.
Dose Flexibility and Individual Response Variation
While 2.4 mg represents the maximum labeled dose, clinical response varies significantly between individuals based on genetics, metabolism, baseline weight, and concurrent health conditions. Some patients achieve substantial weight loss at 1.7 mg and experience side effects at higher doses, making 2.4 mg unnecessary or poorly tolerated. Conversely, other patients may benefit from remaining at 2.4 mg long-term or may require dose adjustments if they plateau in weight loss.
Genetic variation in GLP-1 receptor sensitivity and peptide metabolism influences how individuals respond to semaglutide at different doses. The PlexusDx Precision Peptide Genetic Test identifies key variants in the GLP1R gene (rs6923761) and other pathways affecting peptide response, helping providers anticipate dose requirements and optimize treatment from the start. This genetic insight reduces trial-and-error dosing and accelerates patients toward their effective maintenance dose.
PlexusDx Semaglutide Dosing and Flat-Rate Pricing
PlexusDx delivers compounded semaglutide injections through licensed 503A compounding pharmacies available across all 50 states without insurance requirements or membership fees. The semaglutide injection starts at $149 per month and remains at a flat rate regardless of whether your dose advances from 0.25 mg to 2.4 mg. This pricing model—"Your dose may need to go up. Your price won't."—removes financial barriers to dose optimization and ensures patients can reach their therapeutic target without cost escalation concerns.
All PlexusDx compounded medications are HSA/FSA eligible, expanding access for patients with tax-advantaged health accounts. Patients can request the Precision Peptide Genetic Test at $99 as an add-on after the first month of treatment, enabling personalized dose planning based on their genetic predispositions to GLP-1 pathway response. This combination of affordability, flat pricing, and genetic personalization makes PlexusDx an accessible entry point for semaglutide therapy at any dose level.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What happens if the maximum semaglutide dose of 2.4 mg doesn't produce enough weight loss?
If weight loss plateaus at the maximum dose, providers may extend the treatment timeline, adjust lifestyle factors, or explore combination therapy options like PlexusDx GLP-Squared (semaglutide plus tirzepatide). Genetic testing through PlexusDx's Precision Peptide Genetic Test can reveal whether alternative GLP-1 compounds or dual peptide therapy may offer better results based on your individual pathway activation.
How long does it typically take to reach the maximum semaglutide dose?
Standard titration takes 16 weeks (4 months) to progress from the initial 0.25 mg dose to the 2.4 mg maintenance dose, with increases occurring every 4 weeks. Some patients may require longer intervals between dose steps if side effects emerge, extending the total titration period to 20 weeks or more. PlexusDx providers adjust titration timing based on your tolerance and response, ensuring steady progress toward your therapeutic dose.
Is PlexusDx semaglutide the same medication as Ozempic or Wegovy?
PlexusDx semaglutide is compounded by licensed 503A pharmacies and contains the same active ingredient as branded semaglutide products, but is not FDA-branded. Compounded semaglutide offers equivalent dosing flexibility (0.25 mg to 2.4 mg) at a flat rate starting at $149/month across all dose levels, without insurance requirements.
What side effects are most common when increasing semaglutide doses?
Nausea, decreased appetite, and mild constipation are the most frequently reported side effects during dose escalation, typically subsiding within days to weeks as your body adapts. Severe side effects are uncommon when titration is gradual; however, if persistent nausea or vomiting occurs, your PlexusDx provider can extend the dosing interval or recommend gastrointestinal support measures before advancing further.
How can genetic testing help with semaglutide dosing decisions?
The PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides, including GLP1R variants that influence semaglutide response intensity and optimal dosing. Testing reveals whether you're genetically predisposed to excellent, moderate, or variable response at different doses, enabling your provider to personalize your titration schedule and predict whether you'll benefit most from standard doses or alternative compounds.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic and Thyroid Conditions: What to Know
Optimal Injection Sites: Where to Take Your Ozempic Shot for Best Results